Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Non Operating Investment Income (2022 - 2025)

Historic Non Operating Investment Income for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $29000.0.

  • Orchestra BioMed Holdings' Non Operating Investment Income fell 7603.31% to $29000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$183000.0, marking a year-over-year increase of 2406.64%. This contributed to the annual value of -$68000.0 for FY2024, which is 27777.78% down from last year.
  • As of Q3 2025, Orchestra BioMed Holdings' Non Operating Investment Income stood at $29000.0, which was down 7603.31% from -$21000.0 recorded in Q2 2025.
  • Orchestra BioMed Holdings' Non Operating Investment Income's 5-year high stood at $1.7 million during Q2 2022, with a 5-year trough of -$314000.0 in Q3 2022.
  • Over the past 4 years, Orchestra BioMed Holdings' median Non Operating Investment Income value was -$27000.0 (recorded in 2023), while the average stood at $54133.3.
  • Over the last 5 years, Orchestra BioMed Holdings' Non Operating Investment Income had its largest YoY gain of 19331.21% in 2023, and its largest YoY loss of 10352.6% in 2023.
  • Orchestra BioMed Holdings' Non Operating Investment Income (Quarter) stood at -$165000.0 in 2022, then crashed by 78.18% to -$294000.0 in 2023, then soared by 40.14% to -$176000.0 in 2024, then surged by 116.48% to $29000.0 in 2025.
  • Its Non Operating Investment Income was $29000.0 in Q3 2025, compared to -$21000.0 in Q2 2025 and -$15000.0 in Q1 2025.